US Patent Issued to Neurelis on June 24 for "Administration of benzodiazepine compositions" (American, Belgian Inventors)

ALEXANDRIA, Va., June 25 -- United States Patent no. 12,337,061, issued on June 24, was assigned to Neurelis Inc. (San Diego).

"Administration of benzodiazepine compositions" was invented by Steve Cartt (Hillsborough, Calif.), David Medeiros (Sparks, Nev.), Garry Thomas Gwozdz (Jim Thorpe, Pa.), Andrew Loxley (Brussels), Mark Mitchnick (East Hampton, N.Y.), David Hale (San Diego) and Edward T. Maggio (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions."

The patent was filed on April 15, 2022, under Application No. 17/721,595. ...